Cedar Brook Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,285
Closed -$365K 42
2024
Q1
$365K Buy
1,285
+562
+78% +$164K 0.07% 272
2023
Q4
$219K Sell
723
-23
-3% -$6.27K 0.05% 366
2023
Q3
$200K Buy
+746
New +$186K 0.05% 357
2023
Q2
Sell
-903
Closed -$218K 410
2023
Q1
$218K Sell
903
-117
-11% -$28.7K 0.06% 343
2022
Q4
$268K Buy
1,020
+79
+8% +$21.2K 0.08% 284
2022
Q3
$212K Buy
941
+17
+2% +$4.12K 0.07% 314
2022
Q2
$225K Sell
924
-33
-3% -$8.09K 0.07% 301
2022
Q1
$231K Sell
957
-49
-5% -$11.3K 0.06% 328
2021
Q4
$226K Buy
1,006
+65
+7% +$13.7K 0.06% 338
2021
Q3
$200K Sell
941
-135
-13% -$31.1K 0.06% 333
2021
Q2
$262K Buy
1,076
+88
+9% +$21.6K 0.08% 301
2021
Q1
$246K Sell
988
-149
-13% -$35.6K 0.09% 269
2020
Q4
$261K Sell
1,137
-108
-9% -$24.9K 0.09% 241
2020
Q3
$316K Buy
1,245
+1
+0.1% +$248 0.12% 190
2020
Q2
$293K Buy
1,244
+211
+20% +$48.1K 0.13% 192
2020
Q1
$209K Sell
1,033
-83
-7% -$18.1K 0.12% 218
2019
Q4
$269K Sell
1,116
-55
-5% -$12.1K 0.11% 221
2019
Q3
$227K Sell
1,171
-93
-7% -$17.9K 0.1% 252
2019
Q2
$233K Sell
1,264
-94
-7% -$16.8K 0.11% 252
2019
Q1
$258K Buy
+1,358
New +$259K 0.13% 220

Other funds holding AMGN

Cedar Brook Financial Partners's AMGN Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,285 shares — an estimated $365K sold.

Cedar Brook Financial Partners first reported a position in AMGN in Q1 2019 and held it in 20 quarters. The position peaked at $365K in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 1,285 Amgen shares in Q2 2024, an estimated $365K.
  • Cedar Brook Financial Partners first reported a position in Amgen in Q1 2019 and held it in 20 quarters.
  • Cedar Brook Financial Partners's Amgen position peaked at $365K in Q1 2024.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.